Skip to main content
. 2011 Jul 1;5(3):235. doi: 10.4161/pri.5.3.17416

Figure 5B.

Figure 5B

Comparison of ID50 and specific infectivity in ill hamsters following intracerebral inoculation of PrPSc Brain as a 1% crude brain homogenate (25 µg), PrPSc DRM (1.35 µg) and purified PrPSc DRM-PK-PTA-G100 (0.8 µg). Isolation of PrPSc in DRMs from lipid rafts resulted in a >20-fold increase in specific infectivity relative to crude brain, but much less infectivity was found in the purified PrPSc DRM-PK-PTA-G100 fraction.